Find information on common issues.
Ask questions and find answers from other users.
Suggest a new site feature or improvement.
Check on status of your tickets.
[Illinois] Nanotechnology meets Biology in the Cancer Cell: Applications in Medicine, Drug Delivery, and Determining Drug Efficacy
04 Feb 2016 | | Contributor(s):: Mostafa El-Sayed
[Illinois] Microfluidics and Nanotechnology for Biology and Medicine
08 Aug 2014 | | Contributor(s):: Rashid Bashir
[Illinois] How to Break the "Fundamental" Limits of Nanobiosensing
07 Apr 2014 | | Contributor(s):: Muhammad A. Alam
As the future of Moore’s law of transistor scaling appears uncertain, electronics is being reinvented by broadening the focus to other areas including macroelectronics (electronics of large, possibly flexible and transparent displays), bioelectronics (e.g., nanobio sensors for genomics,...
[Illinois] Evolving Complex Systems in Biology and Medicine
04 Feb 2014 | | Contributor(s):: Dr. Hava Siegelmann
[Illinois] The Role of Nanoparticle Surface Chemistry in Alveolar Macrophage Inflammatory Response
12 Aug 2013 | | Contributor(s):: Valerie Leppert
[Illinois] Beckman Institute Seminar Series
15 Jun 2013 | | Contributor(s):: NanoBio Node
The Beckman Institute Graduate Student Seminar Series presents the work of outstanding graduate students working in Beckman research groups. The seminars begin at Noon in Beckman Institute Room 1005 and are open to the public.The Director's Seminar Lecture Series was designed to encourage...
[Illinois] CNST 2012: Gold Nanoparticles In, On, and Around Cells
02 Jun 2013 | | Contributor(s):: Cathy Murphy
[Illinois] CNST 2012: Nanostructured Silicon Optical Materials as Multifunctional Cell Culture Substrates
02 Jun 2013 | | Contributor(s):: Kris Killian
[Illinois] CNST 2012: Nanotechnology-mediated Sensing of Angiogenesis
02 Jun 2013 | | Contributor(s):: Princess I. Imoukhuede
[Illinois] CNST 2012: Translational Research on Micro and Nanobionics Devices for Mobile and Social Sensing Applications
02 Jun 2013 | | Contributor(s):: Gang Logan Liu
[Illinois] ECE 416: Biosensors
07 Feb 2013 | | Contributor(s):: Brian Cunningham
Learn the underlying engineering principles used to detect small molecules, DNA, proteins, and cells in the context of applications in diagnostic testing, pharmaceutical research, and environmental monitoring. Biosensor approaches including electrochemistry, fluorescence, acoustics, and optics...
[Illinois] B3SI 2012: Circumventing Barriers to Nanoparticle Delivery In Vivo
02 Aug 2012 | | Contributor(s):: Susan E. Clare
[Illinois] Cancer Community Symposium 2012: T Cell Receptors For Potential Cancer Immunotherapy Applications: Single Chain T Cell Receptors Circumvent Mispairing with Endogenous TCR and Mediate T Cell Activity
09 May 2012 | | Contributor(s):: David H. Aggen
To improve the immune response to cancer, gene therapy with tumor-specific T cell-receptors (TCRs) provides an attractive approach to effectively arm patients T cells for tumor cell destruction. A high-affinity TCR specific for an antigenic peptide-major histocompatibility complex (pepMHC) can...
[Illinois] Cancer Community Symposium 2012: Imaging Estrogen Receptors and Estrogen-Receptor Function in Breast Cancer by Positron Emission Tomography (PET): Improved Selection of Patients for Benefit from Endocrine Therapies
09 May 2012 | | Contributor(s):: John A. Katzenellenbogen
The growth of many breast cancers is regulated by estrogens, and these cancers can be treated effectively with endocrine therapies (ET). Identifying patients who will benefit from ET, however, continues to be challenging. Measurement of estrogen receptor (ER) levels in tumor biopsy samples using...
[Illinois] Cancer Community Symposium 2012: The Man with the Crateriform Lesion: Advanced Squamous Cell Carcinoma
09 May 2012 | | Contributor(s):: Joseph Brancheck
Cutaneous squamous cell carcinoma (SCC) is the second most common type of skin cancer in the United States and accounts for 20 percent of non-melanoma skin cancers; in addition, it is the second most common cancer overall in Caucasians. Due to an aging population and increasing sun exposure, the...
[Illinois] Cancer Community Symposium 2012: Speaking Up: The Patient Push for Accelerating Progress in Cancer Research
09 May 2012 | | Contributor(s):: Leslie Hammersmith
Medical research empowers us to fight cancer, and advocacy empowers us to ensure that it addresses the needs of people affected by cancer. Advocacy helps us get through our cancer experiences, stand up for all people affected by cancer and gain a feeling of control over our own healthcare. Young...
[Illinois] Cancer Community Symposium 2012: Materials Science vs. Metastasis
09 May 2012 | | Contributor(s):: Daniel A. Heller
Metastasis, the spread of cancer cells from a primary tumor to seed secondary tumors in distant sites, is one of the greatest challenges in cancer treatment today. For many patients, by the time cancer is detected, metastasis has already occurred. Over 80% of patients diagnosed with lung cancer,...
[Illinois] Cancer Community Symposium 2012: Chemical Imaging for Histopathology: An Emerging Route for Molecular and Structural Analysis of Tissues
09 May 2012 | | Contributor(s):: Michael Walsh
Mid-Infrared (IR) spectroscopic imaging is an emerging approach to derive chemical images from tissues based on their inherent biochemistry. Histologic diagnosis is the gold standard for evaluating the presence and severity of most diseases. Current histopathological techniques use of panel of...
[Illinois] Cancer Community Symposium 2012: Panel Discussion
09 May 2012 |
Please join us for a panel discussion on the social impact of cancer and how it affects patients, providers, clinicians, and researchers alike. We are fortunate to feature Leslie Hammersmith (moderator), Jennifer Smith, and Patience Anders from the local Young Survival Coalition, as well as an...
[Illinois] Cancer Community Symposium 2012: Understanding and Targeting Transcription in Hematological Malignancies
09 May 2012 | | Contributor(s):: Jonathan D. Licht
Abnormalities in the epigenetic regulation of chromatin structure and function can lead to aberrant gene expression and cancer development. Epigenetic regulators can be affected by chromosomal rearrangement, point mutations, deletions and amplifications in cancer. The result may be changes in...